Newsmakers

CytoDyn Completed Submission of All Remaining Parts of Biologics License Application (“BLA”) on May 11, 2020

VANCOUVER, Washington, May 13, 2020 — CytoDyn Submits Requested Datasets to FDA for Biologics License Application CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist […]

No Picture
Trading Ideas

Markets mixed as Powell downplays negative rates

On Wednesday, Jerome Powell shared prepared remarks regarding the future outlook for the U.S. economy, but admits there are ‘longer-term concerns.’ Andrew Slimmon, Morgan Stanley Investment Management Managing Director and Sr. Portfolio Manager, joins Yahoo Finance to discuss. …read more […]